[custom_adv]
The company hopes to make as many as a million-a-week and plans to reserve part of that stock for the NHS. “We have been working on the anti-viral coating since 2011 but it’s only in the last five weeks that we have developed the snood in response to the current pandemic,” said Anna Roberts, of Virustatic Shield.
